Rhumbline Advisers Castle Biosciences Inc Put Options Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
176Shares Held
25.6MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$101 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$77.5 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$52.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$51.2 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$40.5 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $876M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...